Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement
In the treatment of cancer, chemotherapy plays an important role though the efficacy of anti-cancer drug administered orally is limited, due to their poor solubility in physiological medium, inability to cross biological membrane, high Para-glycoprotein (P-gp) mediated drug efflux, and pre-systemic...
Main Authors: | Shashank Chaturvedi, Anurag Verma, Vikas Anand Saharan |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2020-08-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-10-524.pdf |
Similar Items
-
Enhancing the Oral Bioavailability of Candesartan Cilexetil Loaded Nanostructured Lipid Carriers: In Vitro Characterization and Absorption in Rats after Oral Administration
by: Walid Anwar, et al.
Published: (2020-10-01) -
Enhanced Lymphatic Uptake of Leflunomide Loaded Nanolipid Carrier via Chylomicron Formation for the Treatment of Rheumatoid Arthritis
by: Yadhu Krishnan, et al.
Published: (2018-06-01) -
Oncologic Imaging of the Lymphatic System: Current Perspective with Multi-Modality Imaging and New Horizon
by: Mohamed Elshikh, et al.
Published: (2021-09-01) -
Dissecting the Lymphatic System to Predict Melanoma Metastasis
by: Rishi Suresh, et al.
Published: (2020-11-01) -
SUMOylation of pregnane X receptor suppresses rifampicin-induced CYP3A4 and P-gp expression and activity in LS174T cells
by: Huasen Tan, et al.
Published: (2016-02-01)